Login
$ALNY
$160.14 +$0.41 (0.26%) After hours

Company Executives

Officer Age In this role Joined 2025 pay Source
Yvonne L. Greenstreet Also a director
Chief Executive Officer
63 Since 2022
4 years
Not stated $14,867,600
Jeffrey V. Poulton
Executive Vice President and Chief Financial Officer
58 Since 2019
7 years
Not stated $6,863,800
Pushkal Garg
Executive Vice President and Chief Research and Development Officer
58 Since 2025
1 year
2014 $6,490,500
Bryan A. Supran
Executive Vice President, Chief Legal Officer and Secretary
55 Since 2025
1 year
Not stated $6,846,350
Kevin J. Fitzgerald
Executive Vice President, Chief Scientific Officer and Head of Early Research and Early Development
58 Since 2023
3 years
2005 Not reported

Each officer opens the passage of the filing that names them. A title that changed since the list comes from the officer's latest Form 3, 4 or 5, and its start year is not stated there. "Not stated" means the filing does not say. Pay is the proxy's Summary Compensation Table, which reports only the named executive officers.

Board of Directors

From the proxy statement filed Apr 6, 2026 · updated by the 8-K of May 27, 2026

Directors
10
serving now
Independent
7 of 8
stated in the proxy; 2 not stated
Average tenure
7.8 years
from year joined
CEO also chairs the board
No
Amy W. Schulman
Director Age On board Independent Committees Other public boards 2025 pay Source
Amy W. Schulman
65 2014
12 years
Not stated
People, Culture and Compensation Committee Nominating and Corporate Governance Committee
Elevance Health $541,310
Yvonne L. Greenstreet, M.D.
63 2021
5 years
Not independent None stated None stated Paid as CEO
Elliott Sigal, M.D., Ph.D.
74 2022
4 years
Independent
People, Culture and Compensation Committee Science and Technology Committee · Chair
Vir Biotechnology, Inc. $486,310
Dennis A. Ausiello, M.D.
80 2012
14 years
Independent
Nominating and Corporate Governance Committee Science and Technology Committee
Seres Therapeutics, Inc., Rani Therapeutics Holdings, Inc. $479,850
Olivier Brandicourt, M.D.
70 2020
6 years
Independent
People, Culture and Compensation Committee Audit Committee
BeOne Medicines Ltd., Vaxcyte, Inc. $482,350
Peter N. Kellogg
69 2023
3 years
Independent
Audit Committee · Chair
None stated $484,850
David E.I. Pyott
72 2015
11 years
Independent
Nominating and Corporate Governance Committee · Chair
Pliant Therapeutics, Inc., Tarsus Pharmaceuticals $479,850
Margaret A. Hamburg, M.D.
70 2019
7 years
Independent
Nominating and Corporate Governance Committee
None stated $469,850
Colleen F. Reitan
66 2018
8 years
Independent
Audit Committee People, Culture and Compensation Committee · Chair
Myriad Genetics, Inc. $492,350
Benjamin F. Cravatt Joined Jun 1, 2026
- - -
Science and Technology Committee
- -
Nominated to join at the meeting
Not on the board yet; they join only if elected.

Each director opens the passage of the proxy that names them. "Not stated" means the proxy does not say; it never means "no". Pay is the proxy's Director Compensation table; the CEO is paid as an executive. A director marked Joined was added by an 8-K; their row opens that 8-K, and a dash is a value it does not give.

No related-party transactions disclosed

The proxy filed Apr 6, 2026 states there were none.

Read it in the proxy

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support